Global Oncology Academy - Global Oncology Academy

Global Oncology Academy

Global Oncology Academy

Enhance your practice with CME
and tools that focus on the management
and treatment of patients with cancer.

Popular

Managing Immune-Related Adverse Events in Metastatic NSCLC
Managing Immune-Related Adverse Events in Metastatic NSCLC
Project Oncology®
Managing Immune-Related Adverse Events in Metastatic NSCLC
Charles Turck, PharmD, BCPS, BCCCP; Paul Bunn, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Paul Bunn, MD
Communicating Pathologic Response Results in Resectable NSCLC
Communicating Pathologic Response Results in Resectable NSCLC
Project Oncology®
Communicating Pathologic Response Results in Resectable NSCLC
Charles Turck, PharmD, BCPS, BCCCP; Alexander Spira, MD, PhD, FACP
- Charles Turck, PharmD, BCPS, BCCCP
- Alexander Spira, MD, PhD, FACP
- Robert Merritt, MD
Real-World Strategies for Complex cGVHD Treatment Decisions
Real-World Strategies for Complex cGVHD Treatment Decisions
Project Oncology®
Real-World Strategies for Complex cGVHD Treatment Decisions
Brian P. McDonough, MD, FAAFP; Doris M. Ponce, MD, MS
- Brian P. McDonough, MD, FAAFP
- Doris M. Ponce, MD, MS
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
CME/CE
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
Neeraj Agarwal, MD, FASCO; Rana McKay, MD
0.25 credits
- Neeraj Agarwal, MD, FASCO
- Rana McKay, MD
0.25 credits
Emerging Therapeutic Strategies in Metastatic NSCLC
Emerging Therapeutic Strategies in Metastatic NSCLC
Project Oncology®
Emerging Therapeutic Strategies in Metastatic NSCLC
Brian P. McDonough, MD, FAAFP; Urs Weber, MD
- Brian P. McDonough, MD, FAAFP
- Urs Weber, MD
Turning Cold Tumors Hot with mRNA COVID-19 Vaccines
Turning Cold Tumors Hot with mRNA COVID-19 Vaccines
COVID-19: On The Frontlines
Turning Cold Tumors Hot with mRNA COVID-19 Vaccines
Hallie Blevins, PhD; Marlene Mimi Maeusli, PhD.
- Hallie Blevins, PhD
- Marlene Mimi Maeusli, PhD.
Coordinating Care for mCSPC Patients Receiving Androgen Receptor Pathway Inhibitors
Coordinating Care for mCSPC Patients Receiving Androgen Receptor Pathway Inhibitors
Project Oncology®
Coordinating Care for mCSPC Patients Receiving Androgen Receptor Pathway Inhibitors
Charles Turck, PharmD, BCPS, BCCCP; Daniel Geynisman, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Daniel Geynisman, MD
- Jonathan Henderson, MD
Addressing Barriers to CAR T Referral in R/R LBCL
Addressing Barriers to CAR T Referral in R/R LBCL
Project Oncology®
Addressing Barriers to CAR T Referral in R/R LBCL
Steve Jackson, PharmD; Matthew J. Matasar, MD
- Steve Jackson, PharmD
- Matthew J. Matasar, MD
- Tycel Phillips, MD

Medical News

Medical News
Amivantamab Plus Lazertinib in EGFR-Mutant Lung Cancer with CNS Metastases
05/28/2026
Read more
Medical News
Molecular Profiling Guides Adjuvant Therapy in Endometrial Cancer
05/25/2026
Read more
Medical News
BCG Plus Mitomycin Fails to Improve DFS in ANZUP 1301
05/22/2026
Read more
Medical News
Early Postoperative Intake Linked To Complications After GI Cancer Surgery
05/19/2026
Read more

CME/CE

Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
CME/CE
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
Joseph Kim, MD, MPH, MBA, FACHE; Samir Dalia, MD
0.25 credits
- Joseph Kim, MD, MPH, MBA, FACHE
- Samir Dalia, MD
- Christopher Jurief
0.25 credits
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
CME/CE
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Enriqueta Felip, MD; Kristi Orbaugh, MSN, RNP, AOCN
0.25 credits
- Enriqueta Felip, MD
- Kristi Orbaugh, MSN, RNP, AOCN
0.25 credits
Brain Metastases Management: From Detection to Multidisciplinary Care
Brain Metastases Management: From Detection to Multidisciplinary Care
MinuteCE®
Brain Metastases Management: From Detection to Multidisciplinary Care
Barbara O'Brien, MD
1.00 program credit
- Barbara O'Brien, MD
1.00 program credit
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC 
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC 
MinuteCE®
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC 
Benjamin Levy, MD; Melin Khandekar, MD, PhD
1.00 program credit
- Benjamin Levy, MD
- Melin Khandekar, MD, PhD
1.00 program credit

Clinical Practice

Optimizing cGVHD Treatment Decisions in the Second- and Third-Line Settings
Optimizing cGVHD Treatment Decisions in the Second- and Third-Line Settings
Project Oncology®
Optimizing cGVHD Treatment Decisions in the Second- and Third-Line Settings
Charles Turck, PharmD, BCPS, BCCCP; Stephanie Gregory, CNP
- Charles Turck, PharmD, BCPS, BCCCP
- Stephanie Gregory, CNP
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Project Oncology®
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Charles Turck, PharmD, BCPS, BCCCP; Laura Alder, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Laura Alder, MD
- Christine Bestvina, MD
Navigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
Navigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
Project Oncology®
Navigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
Alexandria May, PharmD, BCPS; Adam Brufsky, MD, PhD
- Alexandria May, PharmD, BCPS
- Adam Brufsky, MD, PhD
Optimizing Multidisciplinary Care in Perioperative NSCLC
Optimizing Multidisciplinary Care in Perioperative NSCLC
Project Oncology®
Optimizing Multidisciplinary Care in Perioperative NSCLC
Steve Jackson, PharmD; David Tom Cooke, MD, FACS
- Steve Jackson, PharmD
- David Tom Cooke, MD, FACS
- Joshua Reuss, MD

Programs

Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Project Oncology®
Optimizing First-Line Care for PD-L1–Low Metastatic NSCLC
Charles Turck, PharmD, BCPS, BCCCP; Deepa Rangachari, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Deepa Rangachari, MD
コンテキストにおける意思決定：脳転移に対する全身療法およびCNS療法の順序決定に関する実践的枠組み
コンテキストにおける意思決定：脳転移に対する全身療法およびCNS療法の順序決定に関する実践的枠組み
CME/CE
コンテキストにおける意思決定：脳転移に対する全身療法およびCNS療法の順序決定に関する実践的枠組み
Barbara O'Brien, MD
0.25 credits
- Barbara O'Brien, MD
0.25 credits
Choosing Between Neoadjuvant and Perioperative Strategies in NSCLC
Choosing Between Neoadjuvant and Perioperative Strategies in NSCLC
Project Oncology®
Choosing Between Neoadjuvant and Perioperative Strategies in NSCLC
Steve Jackson, PharmD; Raghava Reddy Induru, MD
- Steve Jackson, PharmD
- Raghava Reddy Induru, MD
Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Project Oncology®
Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP; Neil M. Iyengar, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Neil M. Iyengar, MD
- Sarah H. Donahue, MPH, NP